 |
3ERD |
HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH DIETHYLSTILBESTROL AND A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
3DCT |
FXR with SRC1 and GW4064 |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
3D24 |
Crystal structure of ligand-binding domain of estrogen-related receptor alpha (ERRalpha) in complex with the peroxisome proliferators-activated receptor coactivator-1alpha box3 peptide (PGC-1alpha) |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
3CWD |
Molecular recognition of nitro-fatty acids by PPAR gamma |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
3CS8 |
Structural and Biochemical Basis for the Binding Selectivity of PPARg to PGC-1a |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
3BQD |
Doubling the Size of the Glucocorticoid Receptor Ligand Binding Pocket by Deacylcortivazol |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
3BEJ |
Structure of human FXR in complex with MFA-1 and co-activator peptide |
E |
A |
Nuclear receptor ligand-binding domain |
|
 |
2ZMH |
Crystal Structure of Rat Vitamin D Receptor Bound to Adamantyl Vitamin D Analogs: Structural Basis for Vitamin D Receptor Antagonism and/or Partial Agonism |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
2ZMI |
Crystal Structure of Rat Vitamin D Receptor Bound to Adamantyl Vitamin D Analogs: Structural Basis for Vitamin D Receptor Antagonism and/or Partial Agonism |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
2ZMJ |
Crystal Structure of Rat Vitamin D Receptor Bound to Adamantyl Vitamin D Analogs: Structural Basis for Vitamin D Receptor Antagonism and/or Partial Agonism |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
2ZLC |
2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation and crystal structure |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
2ZLA |
2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation and crystal structure |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
2ZL9 |
2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation and crystal structure |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
2QPY |
AR LBD with small molecule |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
2Q7I |
The Wild Type Androgen Receptor Ligand Binding Domain Bound with Testosterone and an AR 20-30 Peptide |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
2Q7J |
The Wild Type Androgen Receptor Ligand Binding Domain Bound with Testosterone and a TIF2 box 3 Coactivator Peptide 740-753 |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
2P54 |
a crystal structure of PPAR alpha bound with SRC1 peptide and GW735 |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
2P1V |
Crystal structure of the ligand binding domain of the retinoid X receptor alpha in complex with 3-(2\'-propoxy)-tetrahydronaphtyl cinnamic acid and a fragment of the coactivator TIF-2 |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
2P1T |
Crystal structure of the ligand binding domain of the retinoid X receptor alpha in complex with 3-(2\'-methoxy)-tetrahydronaphtyl cinnamic acid and a fragment of the coactivator TIF-2 |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
2P1U |
Crystal structure of the ligand binding domain of the retinoid X receptor alpha in complex with 3-(2\'-ethoxy)-tetrahydronaphtyl cinnamic acid and a fragment of the coactivator TIF-2 |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
2OVH |
Progesterone Receptor with Bound Asoprisnil and a Peptide from the Co-Repressor SMRT |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
2O4R |
Crystal Structure of Rat Vitamin D Receptor Ligand Binding Domain Complexed with VitIII 17-20E and the NR2 Box of DRIP 205 |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
2O4J |
Crystal Structure of Rat Vitamin D Receptor Ligand Binding Domain Complexed with VitIII 17-20Z and the NR2 Box of DRIP 205 |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
2NV7 |
Crystal Structure of Estrogen Receptor Beta Complexed with WAY-555 |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
2J7Y |
STRUCTURE OF 17-EPIESTRIOL-BOUND ESTROGEN RECEPTOR BETA LBD IN COMPLEX WITH LXXLL MOTIF FROM NCOA5 |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
2J7X |
STRUCTURE OF ESTRADIOL-BOUND ESTROGEN RECEPTOR BETA LBD IN COMPLEX WITH LXXLL MOTIF FROM NCOA5 |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
2HFP |
Crystal Structure of PPAR Gamma with N-sulfonyl-2-indole carboxamide ligands |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
2GTK |
Structure-based Design of Indole Propionic Acids as Novel PPARag CO-Agonists |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
2GPO |
Estrogen Related Receptor-gamma ligand binding domain complexed with a synthetic peptide from RIP140 |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
2FVJ |
A novel anti-adipogenic partial agonist of peroxisome proliferator-activated receptor-gamma (PPARG) recruits pparg-coactivator-1 alpha (PGC1A) but potentiates insulin signaling in vitro |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
2AO6 |
Crystal structure of the human androgen receptor ligand binding domain bound with TIF2(iii) 740-753 peptide and R1881 |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
1ZGY |
Structural and Biochemical Basis for Selective Repression of the Orphan Nuclear Receptor LRH-1 by SHP |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
1YYE |
Crystal structure of estrogen receptor beta complexed with way-202196 |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
1XOW |
Crystal structure of the human androgen receptor ligand binding domain bound with an androgen receptor NH2-terminal peptide, AR20-30, and R1881 |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
1XB7 |
X-ray structure of ERRalpha LBD in complex with a PGC-1alpha peptide at 2.5A resolution |
P |
A |
Nuclear receptor ligand-binding domain |
|
 |
1X7J |
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH GENISTEIN |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
1X7B |
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH ERB-041 |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
1X78 |
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-244 |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
1X76 |
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-697 |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
1U9E |
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-397 |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
1U3S |
Crystal Structure of Estrogen Receptor beta complexed with WAY-797 |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
1U3R |
Crystal Structure of Estrogen Receptor beta complexed with WAY-338 |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
1TFC |
CRYSTAL STRUCTURE OF THE LIGAND-BINDING DOMAIN OF THE ESTROGEN-RELATED RECEPTOR GAMMA IN COMPLEX WITH A STEROID RECEPTOR COACTIVATOR-1 PEPTIDE |
D |
B |
Nuclear receptor ligand-binding domain |
|
 |
1T7R |
Crystal structure of the androgen receptor ligand binding domain in complex with a FxxLF motif |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
1T76 |
Crystal structure of the androgen receptor ligand binding domain in complex with a WxxVW motif |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
1T79 |
Crystal structure of the androgen receptor ligand binding domain in complex with a FxxLW motif |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
1T7F |
Crystal structure of the androgen receptor ligand binding domain in complex with a LxxLL motif |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
1T7M |
Crystal structure of the androgen receptor ligand binding domain in complex with a FxxYF motif |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
1T74 |
Crystal structure of the androgen receptor ligand binding domain in complex with a WxxLF motif |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
1T73 |
Crystal structure of the androgen receptor ligand binding domain in complex with a FxxFF motif |
B |
A |
Nuclear receptor ligand-binding domain |
|